Nevertheless, given the NAFLD/NASH results, in our view, the role of adiponectin depends on the different isoforms and receptors involved as well as on the type of liver and surgical conditions (as discussed in Section 5 and Section 6 of the current review). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.